Download this Paper Open PDF in Browser

The Challenge of Developing Oversight Approaches to Nanobiotechnology

8 Pages Posted: 6 Jan 2011  

Susan M. Wolf

University of Minnesota Law School

Gurumurthy Ramachandran, PhD

University of Minnesota, Twin Cities

Jennifer Kuzma

University of Minnesota, Twin Cities - Hubert H. Humphrey Institute of Public Affairs

Jordan Paradise

Loyola University Chicago School of Law

Multiple version iconThere are 2 versions of this paper

Date Written: Winter 2009

Abstract

This symposium of 19 articles grows out of a 4-year project funded by the National Science Foundation (NSF) (grant #SES-0608791) on “Evaluating Oversight Models for Active Nanostructures and Nanosystems: Learning from Past Technologies in a Societal Context” (Susan M. Wolf, Principal Investigator (PI); Co-PIs: Efrosini Kokkoli, Jennifer Kuzma, Jordan Paradise, Gurumurthy Ramachandran). The goal of this project was to develop oversight recommendations for nanobiotechnology grounded in historical analysis and evaluation of oversight approaches to five cognate technologies: drugs, devices, human gene transfer research (“gene therapy”), chemicals in the workplace, and genetically modified organisms in the food supply. The investigators utilized expert elicitation and literature analysis to develop a structured survey to aid analysis of the successes and failures of these prior oversight regimes. The methodology is presented in the symposium and described in depth in additional team publications cited here. The survey instrument devised represents a significant new tool for evaluating science and technology oversight, including regulatory regimes.

This symposium publishes the five historical case studies plus commentaries, an article co-authored by the investigators comparing across the five case studies to derive overarching lessons for nanobio oversight, and seven articles on cross-cutting ideas including nanobio governance and oversight, risk communication, and approaches to expert elicitation. The symposium includes the work of 30 authors and breaks new ground on policy approaches to emerging science and technology.

Keywords: nanotechnology, nanobiotechnology, law and science, technology oversight, science oversight, regulation of science and technology, emerging technologies, law and empirical studies. FDA, EPA, OSHA, NIOSH, NIH, RAC, USDA, NNI

Suggested Citation

Wolf, Susan M. and Ramachandran, PhD, Gurumurthy and Kuzma, Jennifer and Paradise, Jordan, The Challenge of Developing Oversight Approaches to Nanobiotechnology (Winter 2009). Journal of Law, Medicine and Ethics, Vol. 37, No. 4, p. 535, Winter 2009. Available at SSRN: https://ssrn.com/abstract=1735048

Susan M. Wolf (Contact Author)

University of Minnesota Law School ( email )

229 19th Avenue South
Minneapolis, MN 55455
United States
612-625-3406 (Phone)
612-624-9143 (Fax)

HOME PAGE: http://www.law.umn.edu/facultyprofiles/wolfs.html

Gurumurthy Ramachandran, PhD

University of Minnesota, Twin Cities ( email )

420 Delaware St. SE
Minneapolis, MN 55455
United States

Jennifer Kuzma

University of Minnesota, Twin Cities - Hubert H. Humphrey Institute of Public Affairs ( email )

301 19th Ave S
Minneapolis, MN 55455
United States

Jordan K. Paradise

Loyola University Chicago School of Law ( email )

25 E. Pearson
Chicago, IL 60611
United States

Paper statistics

Downloads
33
Abstract Views
719